A drug comorbidity index to predict mortality in men with castration resistant prostate cancer.
<h4>Background</h4>The Charlson Comorbidity Index is a poor predictor of mortality in men with castration resistant prostate cancer (CRPC). To improve this prediction, we created a comorbidity index based on filled prescriptions intended to be used in registry-based studies.<h4>Materials and methods...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2021-01-01
|
| Серія: | PLoS ONE |
| Онлайн доступ: | https://doi.org/10.1371/journal.pone.0255239 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|